01—Abstract
Summary
Summary of the 8-K filed February 19, 2025. Cited figures are marked; the original filing is the authoritative source.
CF Industries Holdings, Inc. filed this Form 8-K on February 19, 2025 to furnish its press release (Exhibit 99.1) reporting results for the quarter and year ended December 31, 2024.
For full year 2024, net earnings attributable to common stockholders were $1.22 billiona, or $6.74 per diluted share, versus $1.53 billion, or $7.87 per diluted share, in 2023. EBITDA was $2.33 billion and adjusted EBITDA was $2.28 billion, compared with $2.71 billion and $2.76 billion in 2023. Net sales fell to $5.94 billion from $6.63 billion, as lower average selling prices more than offset higher ammonia volumes from the Waggaman facility.
Natural gas costs in cost of sales declined to $2.40b per MMBtu from $3.67. Net cash from operating activities was $2.27 billion and free cash flow was $1.45 billion. For the fourth quarter of 2024, net earnings attributable to common stockholders were $328 million, or $1.89 per diluted share, with adjusted EBITDA of $562 million, compared with $592 million in the fourth quarter of 2023.
Capital returns were significant: the company repurchased 18.8 million shares for $1.51 billionc in 2024 and paid dividends, returning $1.9 billion to shareholders in total. As of December 31, 2024, $1.06 billion remained under the $3 billion share repurchase program, which expires in December 2025. The board declared a quarterly dividend of $0.50 per share.
Management expects a constructive global nitrogen supply-demand balance in the near term, supported by low global inventories and high European curtailments, and projects 2025 gross ammonia production of about 10 million tons and capital expenditures of $500d-550 million. Strategic updates include a FEED study estimating about $4.0 billion for a proposed autothermal reforming ammonia facility with carbon capture at Blue Point, with final investment decisions expected in the first quarter of 2025, and a Donaldsonville electrolyzer project whose commissioning was suspended after a fourth-quarter 2024 issue.
02—Key points
Key Highlights
- Full year 2024 net earnings attributable to common stockholders of $1.22 billion ($6.74 per diluted share), down from $1.53 billion ($7.87 per diluted share) in 2023.
- Full year 2024 adjusted EBITDA of $2.28 billion, compared with $2.76 billion in 2023; fourth quarter adjusted EBITDA was $562 million versus $592 million a year earlier.
- Net sales of $5.94 billion for 2024 versus $6.63 billion in 2023, driven by lower average selling prices across products.
- Net cash from operating activities of $2.27 billion and free cash flow of $1.45 billion for 2024.
- Repurchased 18.8 million shares for $1.51 billion in 2024; $1.06 billion remains under the $3 billion program expiring December 2025.
- Quarterly dividend of $0.50 per common share declared January 30, 2025, payable February 28, 2025.
- ATR ammonia facility at Blue Point with an estimated cost of about $4.0 billion; final investment decision expected in the first quarter of 2025.
03—Questions
Frequently Asked Questions
Why did earnings decline in 2024?
The filing attributes the decline mainly to lower average selling prices across ammonia, granular urea, UAN and AN, as lower global energy costs reduced the global market clearing price. Lower realized natural gas costs ($2.40 per MMBtu versus $3.67 in 2023) partly offset this, and higher maintenance costs were also a factor.
What drove the increase in ammonia sales volume?
Ammonia sales volume rose because of contractual commitments served from the Waggaman, Louisiana, ammonia production facility, which the company acquired on December 1, 2023.
How much capital is the company returning to shareholders?
The company returned $1.9 billion in 2024 through share repurchases and dividends. Repurchases totaled $1.51 billion for 18.8 million shares, and $1.06 billion remains under the share repurchase program as of December 31, 2024.
What are the company's capital spending plans and key project timelines?
Capital expenditures were $518 million in 2024 and are projected at $500-550 million for 2025. The Yazoo City CCS project is expected to start up in 2028, the Donaldsonville CCS project in 2025, and the Blue Point ATR facility's final investment decision is expected in the first quarter of 2025.
What is the outlook for nitrogen markets?
Management expects the near-term global supply-demand balance to remain constructive because inventories are believed to be below average and European marginal producers face challenging economics. Over the longer term, it expects global nitrogen capacity growth over the next four years not to keep pace with expected demand growth of about 1.5% per year for traditional applications, and it expects North American producers to keep a cost advantage.
04—Continue